Search research articles
Contact Us
Filters
Showing results (11-20 of 17) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 17 results.
Carbohydrate Research
|
June 8, 2011
1-Deoxy-D-galactonojirimycins with dansyl capped N-substituents as β-galactosidase inhibitors and potential probes for GM1 gangliosidosis affected cell lines
Richard F G Fröhlich, Richard H Furneaux, Don J Mahuran, et al.
Carbohydrate Research
|
May 18, 2010
1-Deoxynojirimycins with dansyl capped N-substituents as probes for Morbus Gaucher affected cell lines
Richard F G Fröhlich, Richard H Furneaux, Don J Mahuran, et al.
Molecular Therapy. Methods & Clinical Development
|
June 26, 2023
Efficacy and muscle safety assessment of fukutin-related protein gene therapy
Halli Benasutti, Joseph W Maricelli, Jane Seto, et al.
Progress in Molecular Biology and Translational Science
|
December 6, 2011
Animal models of muscular dystrophy
Rainer Ng, Glen B Banks, John K Hall, et al.
Nature Chemical Biology
|
July 28, 2015
The amylase inhibitor montbretin A reveals a new glycosidase inhibition motif
Leslie K Williams, Xiaohua Zhang, Sami Caner, et al.
ACS Central Science
|
April 12, 2016
Potent Human α-Amylase Inhibition by the β-Defensin-like Protein Helianthamide
Christina Tysoe, Leslie K Williams, Robert Keyzers, et al.
Beilstein Journal of Organic Chemistry
|
May 27, 2010
Synthesis of lipophilic 1-deoxygalactonojirimycin derivatives as D-galactosidase inhibitors
Georg Schitter, Elisabeth Scheucher, Andreas J Steiner, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 17) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 17 results.
Carbohydrate Research
|
June 8, 2011
1-Deoxy-D-galactonojirimycins with dansyl capped N-substituents as β-galactosidase inhibitors and potential probes for GM1 gangliosidosis affected cell lines
Richard F G Fröhlich, Richard H Furneaux, Don J Mahuran, et al.
Carbohydrate Research
|
May 18, 2010
1-Deoxynojirimycins with dansyl capped N-substituents as probes for Morbus Gaucher affected cell lines
Richard F G Fröhlich, Richard H Furneaux, Don J Mahuran, et al.
Molecular Therapy. Methods & Clinical Development
|
June 26, 2023
Efficacy and muscle safety assessment of fukutin-related protein gene therapy
Halli Benasutti, Joseph W Maricelli, Jane Seto, et al.
Progress in Molecular Biology and Translational Science
|
December 6, 2011
Animal models of muscular dystrophy
Rainer Ng, Glen B Banks, John K Hall, et al.
Nature Chemical Biology
|
July 28, 2015
The amylase inhibitor montbretin A reveals a new glycosidase inhibition motif
Leslie K Williams, Xiaohua Zhang, Sami Caner, et al.
ACS Central Science
|
April 12, 2016
Potent Human α-Amylase Inhibition by the β-Defensin-like Protein Helianthamide
Christina Tysoe, Leslie K Williams, Robert Keyzers, et al.
Beilstein Journal of Organic Chemistry
|
May 27, 2010
Synthesis of lipophilic 1-deoxygalactonojirimycin derivatives as D-galactosidase inhibitors
Georg Schitter, Elisabeth Scheucher, Andreas J Steiner, et al.
Page
of 2